Search - tctmd.com

Displaying 481 - 500 of 519

Sort: Relevancy | Date

News Daily News

NEXT Up: Polymer-Free SES Angiographically Superior to Taxus

January 24, 2012

News Daily News

Early Percutaneous Intervention May Help Asymptomatic Mitral Stenosis

Caitlin E. Cox

January 17, 2012

Presentation TCT 2012

Use of the REG1 Anticoagulation System During PCI May Improve Bleeding and Ischemic Complications Compared with Heparin: A PCI Substudy from the Phase 2B RADAR Trial

Presenter: Thomas J. Povsic, John P. Vavalle, Laura H. Aberle, Steven L. Zelenkofske, Roxana Mehran, Mauricio G. Cohen, Christopher E. Buller, Jan H. Cornel, Jaroslaw D. Kasprzak, Gilles Montalescot, Peter Fail, Ian J. Sarembock, John H. Alexander

January 03, 2012

News Daily News

New-Onset A-fib After Percutaneous Valve Repair More Common Than Thought

December 13, 2011

News Daily News

Catheter-Directed Thrombolysis Beneficial for Proximal DVT

Yael L. Maxwell

December 12, 2011

News Daily News

CAS for Acute Stroke Feasible - But Controversial

Leah Lawrence

November 20, 2011

News Conference News

Drug-Eluting Balloons an Option for Patients with BMS Restenosis, High Bleeding Risk

November 17, 2011

News Industry News

Boston Scientific's WATCHMAN® Device Implanted in First Patients in Latin America

November 15, 2011

News Conference News

ISAR-REACT 4: Bivalirudin Reduces Major Bleeding in NSTEMI Patients

November 13, 2011

News Industry News

First Research Results of Angiomax(R) (Bivalirudin) Versus Heparin in Transcatheter Aortic Valve Interventions Reported at TCT

November 07, 2011

News Industry News

Regado Biosciences, Inc. Presents Positive Efficacy and Safety Substudy Data from the Phase 2b RADAR Trial for the REG1 Anticoagulation System

November 06, 2011

News Conference News

Coming to Grips with CLOSURE I: PFO Device Plus Medical Therapy Not Superior to Medical Therapy Alone

November 06, 2011

News Daily News

FDA Approves Sapien Transcatheter Valve for Inoperable Aortic Stenosis

Yael L. Maxwell

November 03, 2011

News Industry News

FDA approves first artificial aortic heart valve placed without open-heart surgery

November 02, 2011

News Daily News

Meta-analysis: Intracoronary vs. IV Abciximab Improves Survival in STEMI Patients

L.A. McKeown

November 01, 2011

News Daily News

First-Year Stent Thombosis Risk High—and Dangerous—in ACS Patients

October 31, 2011

News Daily News

Delayed Stenting Optimizes Microvascular Perfusion in STEMI Patients

October 26, 2011

News Daily News

Bivalirudin Decreases Bleeding Regardless of Heparin Anticoagulation Level

Yael L. Maxwell

October 13, 2011

News Daily News

Rivaroxaban Continues Emergence of New Class of Anticoagulants for A-Fib

Caitlin E. Cox

September 14, 2011

News Daily News

Prothrombin Works as Antidote to Rivaroxaban, Not Dabigatran

L.A. McKeown

September 13, 2011

Advertisement

NEXT Up: Polymer-Free SES Angiographically Superior to Taxus

Early Percutaneous Intervention May Help Asymptomatic Mitral Stenosis

Use of the REG1 Anticoagulation System During PCI May Improve Bleeding and Ischemic Complications Compared with Heparin: A PCI Substudy from the Phase 2B RADAR Trial

New-Onset A-fib After Percutaneous Valve Repair More Common Than Thought

Catheter-Directed Thrombolysis Beneficial for Proximal DVT

CAS for Acute Stroke Feasible - But Controversial

Drug-Eluting Balloons an Option for Patients with BMS Restenosis, High Bleeding Risk

Boston Scientific's WATCHMAN® Device Implanted in First Patients in Latin America

ISAR-REACT 4: Bivalirudin Reduces Major Bleeding in NSTEMI Patients

First Research Results of Angiomax(R) (Bivalirudin) Versus Heparin in Transcatheter Aortic Valve Interventions Reported at TCT

Regado Biosciences, Inc. Presents Positive Efficacy and Safety Substudy Data from the Phase 2b RADAR Trial for the REG1 Anticoagulation System

Coming to Grips with CLOSURE I: PFO Device Plus Medical Therapy Not Superior to Medical Therapy Alone

FDA Approves Sapien Transcatheter Valve for Inoperable Aortic Stenosis

FDA approves first artificial aortic heart valve placed without open-heart surgery

Meta-analysis: Intracoronary vs. IV Abciximab Improves Survival in STEMI Patients

First-Year Stent Thombosis Risk High—and Dangerous—in ACS Patients

Delayed Stenting Optimizes Microvascular Perfusion in STEMI Patients

Bivalirudin Decreases Bleeding Regardless of Heparin Anticoagulation Level

Rivaroxaban Continues Emergence of New Class of Anticoagulants for A-Fib

Prothrombin Works as Antidote to Rivaroxaban, Not Dabigatran

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content